Next Science Ltd Total Liabilities

Latest as of June 2025: AU$10.02 Million AUD ≈ $7.09 Million USD

Next Science Ltd total liabilities. Based on the latest financial reports, Next Science Ltd (NXS) has total liabilities worth AU$10.02 Million AUD (≈ $7.09 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Next Science Ltd liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Next Science Ltd (2016–2024)

Total liabilities of Next Science Ltd from 2016 to 2024. This chart illustrates how Next Science Ltd's total liabilities have evolved over time, based on quarterly financial data.

Next Science Ltd Competitors by Total Liabilities

The table below lists competitors of Next Science Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Daewoo Elec Co KO:009320	Korea	₩83.76 Billion
Atico Mining Corporation V:ATY	Canada	CA$65.45 Million
Columbus Acquisition Corp Unit NASDAQ:COLAU	USA	$310.21K
GAMBLING.COM GRP ON F:6WH	Germany	€179.78 Million
Yellow Balloon Tour Co. Ltd KQ:104620	Korea	₩64.96 Billion
Shanghai Lingyun Industries Development Co Ltd SHG:900957	China	$423.71 Million
Health In Tech, Inc. Class A Common Stock NASDAQ:HIT	USA	$7.36 Million
Wattana Karnpaet Public Company Limited BK:NEW	Thailand	฿110.88 Million

Liability Composition Analysis (2016–2024)

This chart breaks down Next Science Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see NXS total assets.

Liquidity & Leverage Metrics

Next Science Ltd Total Liabilities Ratios Explained

Next Science Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	1.38	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-17.98	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	1.06	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Next Science Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Next Science Ltd (2016–2024)

The table below shows the annual total liabilities of Next Science Ltd from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	AU$5.77 Million ≈ $4.08 Million	+13.63%
2023-12-31	AU$5.08 Million ≈ $3.59 Million	-22.14%
2022-12-31	AU$6.52 Million ≈ $4.62 Million	+121.78%
2021-12-31	AU$2.94 Million ≈ $2.08 Million	-37.37%
2020-12-31	AU$4.70 Million ≈ $3.32 Million	+40.70%
2019-12-31	AU$3.34 Million ≈ $2.36 Million	+36.73%
2018-12-31	AU$2.44 Million ≈ $1.73 Million	+336.36%
2017-12-31	AU$559.46K ≈ $395.85K	+125.39%
2016-12-31	AU$248.22K ≈ $175.63K	--

About Next Science Ltd

AU:NXS Australia Drug Manufacturers - Specialty & Generic

Market Cap

$30.02 Million

AU$42.43 Million AUD

Market Cap Rank

#23549 Global

#887 in Australia

Share Price

AU$0.15

Change (1 day)

+0.00%

52-Week Range

AU$0.14 - AU$0.15

All Time High

AU$4.60